Global Custom Market Research Reports Provider Company

phone

Alembic Pharmaceuticals Ltd (APLLTD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Published Date: 11 Apr 2018
  • Number of Pages: 35
  • Category: Pharmaceuticals
  • Country: India
Summary

Alembic Pharmaceuticals Ltd (APL) is a pharmaceutical company which manufactures and markets generic pharmaceutical products. The companys active pharmaceutical ingredients include macrolides, NSAIDs, and other drugs. It also offers branded formulations in the areas of antibiotics and antibacterial, cardiovascular, gynecological, cough and cold, gastroenterological, ophthalmological, anti-diabetic, orthopedic, urology, antihistamine, dermatological and herbal nutraceuticals. APL provides generic formulations such as anti-allergic, anthelmintic, antimicrobials, antiulcerants, nutritional and vitamin preparations, and others speciality products. The company operates through its research centres and manufacturing facilities in Vadodara, Gujarat and Baddi. APL is headquartered in Vadodara, Gujarat, India.

Alembic Pharmaceuticals Ltd (APLLTD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData

3
List of Tables 4
List of Figures 4
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alembic Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Alembic Pharma to Form Joint Venture with Orbicular Pharma 11
TG Therapeutics Enters Into Agreement With Rhizen Pharma To Develop PI3K Delta Inhibitor, TGR-1202 12
Licensing Agreements 14
TG Therapeutics Exercises Option for Licensing Agreement with Rhizen Pharma To Develop PI3K Delta Inhibitor, TGR-1202 14
Novartis Enters into Licensing Agreement with Rhizen Pharma 16
Ranbaxy Pharma Enters Into Licensing Agreement With Alembic Pharma For Desvenlafaxine Base Extended-Release Tablets 17
Accu-Break Pharma Enters Into Licensing Agreement With Alembic Pharma To Develop Novel Pharma Products 18
Asset Transactions 19
Alembic Pharma Sells its Formulations Manufacturing Facility to Scott-Edil Pharmacia 19
Acquisition 20
Alembic Pharma Acquires Orit Labs 20
Alembic Pharma to Acquire 49% Stake in Adwiya Mami 21
Alembic Pharmaceuticals Ltd - Key Competitors 22
Alembic Pharmaceuticals Ltd - Key Employees 23
Alembic Pharmaceuticals Ltd - Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 26
Financial Announcements 26
Jul 20, 2017: Alembic Pharmaceuticals: QI Net Revenue at Rs 648 Crores, Net Profit at Rs 65 Crores 26
May 03, 2017: Alembic Pharmaceuticals: Q4 Net Revenue grew 18% to Rs 740 Crores, Net Profit at Rs 94 cr 28
Jan 25, 2017: Alembic Pharmaceuticals: Q3 Net Profit at Rs 86 cr, Net Revenues at Rs 776 cr 29
Legal and Regulatory 30
Mar 21, 2018: USFDA Inspection Formulation Facility at Panelav 30
Aug 31, 2017: Alembic Pharmaceuticals Receives EU GMP Certificate For Its Formulation Facility At Panelav 31
Mar 10, 2017: Alembic Pharmaceuticals Announces US FDA Inspection at Baroda Facility 32
Government and Public Interest 33
Apr 17, 2017: Successful US FDA Inspection at Alembic Pharmaceuticals Bioequivalence Facility at Baroda 33
Other Significant Developments 34
Aug 18, 2017: Alembic Pharmaceuticals: Disruption in plant operations at Algerian JV 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List Of Tables

List of Tables
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alembic Pharmaceuticals Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Alembic Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Alembic Pharma to Form Joint Venture with Orbicular Pharma 11
TG Therapeutics Enters Into Agreement With Rhizen Pharma To Develop PI3K Delta Inhibitor, TGR-1202 12
TG Therapeutics Exercises Option for Licensing Agreement with Rhizen Pharma To Develop PI3K Delta Inhibitor, TGR-1202 14
Novartis Enters into Licensing Agreement with Rhizen Pharma 16
Ranbaxy Pharma Enters Into Licensing Agreement With Alembic Pharma For Desvenlafaxine Base Extended-Release Tablets 17
Accu-Break Pharma Enters Into Licensing Agreement With Alembic Pharma To Develop Novel Pharma Products 18
Alembic Pharma Sells its Formulations Manufacturing Facility to Scott-Edil Pharmacia 19
Alembic Pharma Acquires Orit Labs 20
Alembic Pharma to Acquire 49% Stake in Adwiya Mami 21
Alembic Pharmaceuticals Ltd, Key Competitors 22
Alembic Pharmaceuticals Ltd, Key Employees 23
Alembic Pharmaceuticals Ltd, Other Locations 24
Alembic Pharmaceuticals Ltd, Subsidiaries 24

List Of Figures

List of Figures
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alembic Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 9

Alembic Pharmaceuticals Ltd (APL) is a pharmaceutical company which manufactures and markets generic pharmaceutical products. The companys active pharmaceutical ingredients include macrolides, NSAIDs, and other drugs. It also offers branded

View Report

Alembic Pharmaceuticals Ltd (APL) is a pharmaceutical company which manufactures and markets generic pharmaceutical products. The companys active pharmaceutical ingredients include macrolides, NSAIDs, and other drugs. It also offers branded

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports